People: Monsanto Co (MON.N)

MON.N on New York Stock Exchange

114.94USD
2 Sep 2014
Price Change (% chg)

$-0.71 (-0.61%)
Prev Close
$115.65
Open
$115.90
Day's High
$115.92
Day's Low
$114.60
Volume
596,955
Avg. Vol
907,658
52-wk High
$128.77
52-wk Low
$98.89

Search Stocks

Parfet, William 

Brief Biography

Mr. William U. Parfet is Independent Director of Monsanto Co. Chairman, Chief Executive Officer and President of MPI Research, Inc., a pre-clinical toxicology research laboratory, since 2012; Chairman and Chief Executive Officer of MPI Research, Inc., 1999-2012; Co-Chairman of MPI Research, LLC, 1995-1999. Public Company Directorships in the Last Five Years: Stryker Corporation; Taubman Centers, Inc. Mr. Parfet has served as an executive or director for multiple companies during his career, with broad experience in global business management and finance. As president of a major pharmaceutical company, he gained expertise in the areas of strategic planning, technology, marketing, and global business management, and he is knowledgeable about the chemical, pharmaceutical, food and agricultural industries. In particular, Mr. Parfet’s past roles as CFO, controller, and treasurer of a multi-national corporation, service on the audit committees for other public companies, and past service as a trustee of the Financial Accounting Foundation (which oversees FASB and GASB) and Chairman of Financial Executive International, enable him to provide expert guidance and oversight of our management in his role as chair of our audit and finance committee. In addition, his service on the governance committees of other public companies, including serving as lead independent director, enables Mr. Parfet to provide insight and value to our governance and compliance processes.

Basic Compensation

Total Annual Compensation, Long-Term Incentive Plans, All Other, Fiscal Year Total,
-- -- -- --

Options Compensation

  Quantity Market Value
Exercisable -- --
Unexercisable -- --
Exercised -- --
Name Fiscal Year Total

Hugh Grant

12,574,200

Brett Begemann

3,895,170

Pierre Courduroux

3,143,040

Robert Fraley

3,901,680

David Snively

3,148,730

Steven Mizell

--
As Of 30 Aug 2013
Search Stocks